Bisphosphonates for Young Patients With Low Bone Mineral Density

被引：0
|
作者：
Rosen, Harold N. [1 ]
机构：
[1] Beth Israel Deaconess Med Ctr, Dept Med, Div Endocrinol & Metab, 330 Brookline Ave, Boston, MA 02215 USA
来源：
ENDOCRINE PRACTICE | 2021年 / 27卷 / 10期
关键词：
PREMENOPAUSAL WOMEN; DOUBLE-BLIND; PREVENTION; FRACTURE;
D O I：
10.1016/j.eprac.2021.07.009
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：975 / 976
页数：2
相关论文
共 50 条
  • [31] High prevalence of low bone mineral density in young adults with phenylketonuria
    Ciki, Kismet
    Kahraman, Ayca Burcu
    Akar, Halil Tuna
    Yildiz, Yilmaz
    Dursun, Ali
    Tokatli, Ayseguel
    Coskun, Turgay
    Sivri, Serap
    POSTGRADUATE MEDICINE, 2025, 137 (01) : 86 - 92
  • [32] Discrepant areal and volumetric bone density measurements in a young woman with low bone mineral density.
    Schussheim, DH
    Rubin, MR
    Shane, E
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S458 - S458
  • [33] Bone mineral density in patients with rheumatoid arthritis: relation between disease severity and low bone mineral density
    Lodder, MC
    de Jong, Z
    Kostense, PJ
    Molenaar, ETH
    Staal, K
    Voskuyl, AE
    Hazes, JMW
    Dijkmans, BAC
    Lems, WF
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (12) : 1576 - 1580
  • [34] Effects of denosumab on bone mineral density and bone turnover markers in rheumatoid arthritis patients switching from bisphosphonates
    Tetsuya Kaneko
    Koichi Okamura
    Yukio Yonemoto
    Chisa Okura
    Takahito Suto
    Masahiro Tachibana
    Hideo Sakane
    Makoto Inoue
    Hirotaka Chikuda
    Journal of Experimental Orthopaedics, 6
  • [35] Effects of denosumab on bone mineral density and bone turnover markers in rheumatoid arthritis patients switching from bisphosphonates
    Kaneko, Tetsuya
    Okamura, Koichi
    Yonemoto, Yukio
    Okura, Chisa
    Suto, Takahito
    Tachibana, Masahiro
    Sakane, Hideo
    Inoue, Makoto
    Chikuda, Hirotaka
    JOURNAL OF EXPERIMENTAL ORTHOPAEDICS, 2019, 6 (01)
  • [36] Effects of denosumab on bone mineral density and bone turnover in patients with rheumatoid arthritis receiving concurrent glucocorticoids or bisphosphonates
    Dore, Robin K.
    Cohen, Stanley B.
    Lane, Nancy E.
    Palmer, William
    Shergy, William
    Zhou, Lifen
    Wang, Huei
    Tsuji, Wayne
    Newmark, Richard
    ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (05) : 872 - 875
  • [37] Differences in alveolar bone mineral density by tooth type in female osteoporotic patients treated with bisphosphonates
    Kubo, Ryuta
    Yoshida, Ryoji
    Baba-Tajiri, Rui
    Nakamura-Yamada, Hibiki
    Miyahara, Tomoya
    Ooyama, Toru
    Inoue, Junki
    Hirosue, Akiyuki
    Kawahara, Kenta
    Nakamoto, Masafumi
    Hirayama, Masatoshi
    Miyamoto, Takeshi
    Nakayama, Hideki
    ORAL SCIENCE INTERNATIONAL, 2025, 22 (01)
  • [38] The effect of bisphosphonates and infliximab on bone mineral density in patients with Chron's disease and osteopenia or osteoporosis
    Rhim, AD
    Weinberg, A
    Lichtenstein, GR
    GASTROENTEROLOGY, 2003, 124 (04) : A7 - A7
  • [39] Bone mineral density improves during 2 years of treatment with bisphosphonates in patients with ankylosing spondylitis
    Arends, Suzanne
    Wink, Freke
    Veneberg, Joyce
    Bos, Reinhard
    van Roon, Eric
    van der Veer, Eveline
    Maas, Fiona
    Spoorenberg, Anneke
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (02) : 644 - 651
  • [40] Effect of Bisphosphonates on Bone Mineral Density and Fracture Prevention in Gastric Cancer Patients After Gastrectomy
    Lim, Jung Sub
    Jin, Sung-Ho
    Kim, Sang Bum
    Lee, Jong-Inn
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2012, 46 (08) : 669 - 674
12345